Makoto Abue
Natori-shi, 9811293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 26, 2024
Delta-6 desaturase FADS2 is a tumor-promoting factor in cholangiocarcinoma.
Journal: Cancer science
Published: February 08, 2024
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma.
Journal: Cancer science
Published: October 11, 2023
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer.
Journal: Biochemical and biophysical research communications
Published: February 27, 2023
Clinical and genomic features of non-small cell lung cancer occurring in families.
Journal: Thoracic cancer
Published: December 11, 2022
A case of anaplastic pancreatic cancer with osteoclast-like giant cells during follow-up of a branch-duct pancreatic intraductal papillary mucinous tumor
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: October 10, 2022
The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life.
Journal: Journal of pancreatic cancer
Published: June 14, 2021
BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Journal: Cancer science
Published: April 08, 2021
Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein.
Journal: Biochemical and biophysical research communications
Published: November 06, 2020
BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Journal: Scientific reports
Published: January 20, 2020
CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: September 03, 2019
Last Updated: 09/26/2026